市場調査レポート

商品コード

神経膠腫治療市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲：疾患別、治療タイプ別、グレード別、エンドユーザー別、地域別

Glioma Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease, Treatment Type, Grade, End User, and Geography

出版日: 2023年09月18日 | 発行: The Insight Partners

| ページ情報: 英文 182 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 712,439円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,025,599円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,338,759円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.58円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の神経膠腫治療市場は、2022年の41億3,960万米ドルから2030年には82億9,250万米ドルに達すると予測されます。同市場は2022年から2030年にかけてCAGR 9.1％で成長すると予測されています。

市場の成長は、膠芽腫、退形成性星細胞腫、乏突起膠腫などの侵攻性脳腫瘍を含む高悪性度神経膠腫の有病率の増加です。しかし、高い治療費が市場の成長をある程度妨げています。

神経膠腫治療市場の市場機会

ブラジル、インド、中国、ロシア、南アフリカは、世界で最も急速に経済成長している国のひとつです。これらの国々やその他の新興経済諸国における医療分野は、今後数年間で急速に拡大すると予測されています。期待される成長の背景には、顧客需要の変化、ヘルスケアサービスに対する意識の高まり、高齢化人口の継続的な増加があります。世界の脳腫瘍治療市場は、ヘルスケア分野の普及に伴い、今後数年間で大きく成長する可能性が高いです。

神経膠腫治療市場を阻害する要因

脳腫瘍の治療には高額な費用がかかるため、治療費の高さが患者のストレスや不安の原因となっています。治療費に加えて、患者のケアに関連する予定外の追加費用も負担する必要があります。高額な医療費は、治療計画の中止を余儀なくさせ、健康を危険にさらし、将来のさらなる出費につながる可能性があります。米国国立医学図書館によると、新たに診断されたテモゾロミド（TMZ）治療によるGBMの直接医療費は、商業保険に加入している患者において相当なものであり、推定累積費用は～268,031米国ドルです。悪性脳腫瘍患者が負担するヘルスケアコストは、同じ人口統計の非がん対照群が負担するコストの20倍です。

神経膠腫治療市場セグメント別概要

神経膠腫治療市場は、タイプ別に星細胞腫、乏突起星細胞腫、乏突起膠腫に区分されます。2022年には、星細胞腫セグメントが最大の市場シェアを占めています。さらに、このセグメントは2022年から2030年にかけて最も高いCAGRを記録すると予測されています。この疾患の有病率の増加と相まって、この疾患とその治療に対する一般市民の認識を高める活動が活発化していることが、神経膠腫治療市場の成長を促進する主な要因の1つです。さらに、退形成性星細胞腫分野の市場参入企業は、研究開発努力の拡大や未開拓の新規市場セグメントから成長機会を得る可能性があります。治療法に基づき、神経膠腫治療市場は手術、化学療法、放射線療法、その他に区分されます。2022年には、外科手術分野が市場最大のシェアを占めています。また、手術は腫瘍を完全に除去するため、最も好まれる手法であることから、同分野は2022年から2030年にかけて最も速いCAGRで需要が伸びると予想されます。悪性度に基づき、神経膠腫治療市場は低悪性度と高悪性度に区分されます。2022年には、高悪性度セグメントが市場で最大のシェアを占めています。また、同セグメントは2022年から2030年にかけて最も速いCAGRで需要が伸びると予想されています。より効果的な治療法や療法を開発するために、高悪性度腫瘍をより深く理解するための複数の研究が進行中です。神経膠腫治療市場は、エンドユーザーに基づいて病院・診療所と外来医療センターに区分されます。2022年には、病院・診療所セグメントが最大の市場シェアを占めています。さらに、同セグメントは2022年から2030年にかけて最も速いCAGRで需要の伸びが見込まれます。さらに、病院数の増加、先進的な診断プラットフォームの採用、新興国市場における病院へのアクセス性の向上は、予測期間中、病院セグメントの神経膠腫治療市場の成長に有利な機会を提供するであろう。

神経膠腫治療市場地理的概観

北米は世界の神経膠腫治療市場で最大のシェアを占めており、アジア太平洋は世界の神経膠腫治療市場で最も急速に成長している地域です。北米の市場は、主に脳腫瘍の有病率の増加、神経膠腫治療の技術的進歩、喫煙者の増加によって、予測期間中に成長すると予想されます。アジア太平洋地域は、世界の神経膠腫治療検査市場で最も高いCAGRを記録しました。同地域の市場は、中国、インド、日本を含む国々で今後数年間に大きく成長すると予想されます。アジア太平洋市場は、脳腫瘍治療に対する需要の増加と脳腫瘍の有病率の上昇によって成長すると予想されています。したがって、この地域は神経膠腫治療市場のプレーヤーにとって、予測期間中に成長する大きな可能性を秘めています。

神経膠腫治療市場に関するレポート作成時に参照した一次情報および二次情報は、世界銀行データ、NHS（National Health Service）、FDA（Food and Drug Administration）、EMA（European Medicines Agency）、EPA（Environmental Protection Agency）などです。

市場促進要因
- 患者が治療を受けられるようにするための地域および州政府の取り組み
- 高悪性度神経膠腫の有病率の増加
主な市場抑制要因
- 診断コストの高さ
主な市場機会
- 新興国におけるヘルスケア分野の進歩
今後の動向
- 神経膠腫治療薬の承認急増
インパクト分析

第6章神経膠腫治療市場：世界市場分析

神経膠腫治療市場の収益、2022年～2030年

第7章神経膠腫治療市場神経膠腫治療の世界市場-2030年までの収益と予測：疾患別

神経膠腫治療市場収益シェア、疾患別、2022年・2030年（%）
星細胞腫
乏突起星細胞腫
乏突起膠腫

第8章神経膠腫治療の世界市場：2030年までの収益と予測：治療タイプ別

神経膠腫治療市場2022年および2030年治療タイプ別売上高シェア（%）
手術療法
化学療法
放射線療法
その他

第9章神経膠腫治療の世界市場：2030年までの収益と予測：グレード別

神経膠腫治療市場の2022年および2030年グレード別収益シェア（%）
低悪性度
高悪性度

第10章神経膠腫治療の世界市場-エンドユーザー別収益と2030年までの予測

神経膠腫治療市場のエンドユーザー別収益シェア（2022年および2030年）
病院および診療所
外来手術センター

第11章神経膠腫治療市場- 地域別分析

北米
- メキシコ
欧州
- その他欧州
アジア太平洋
- その他アジア太平洋地域
中東・アフリカ
- その他中東とアフリカ
中南米
- その他中南米

第12章 COVID-19前後の影響

COVID-19前後の影響

第13章神経膠腫治療神経膠腫治療市場の業界情勢

市場における各社の成長戦略（%）
有機的展開
無機的展開

第14章企業プロファイル

F. Hoffmann-La Roche Ltd
Arbor Pharmaceuticals LLC
Merck & Co Inc
Sun Pharmaceutical Industries Ltd
Amgen Inc
Teva Pharmaceutical Industries Ltd
Pfizer Inc
Amneal Pharmaceuticals Inc
Karyopharm Therapeutics Inc
Biocon Ltd

第15章付録

図表

List Of Tables

Table 1. Glioma Treatment Market Segmentation
Table 2. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 3. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 4. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 5. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 6. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 7. North America Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 8. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 9. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 10. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 11. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 12. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 13. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 15. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 16. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 17. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 18. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 19. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 20. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 21. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 22. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 23. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 24. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 25. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 26. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 27. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 28. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 29. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 30. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 31. Europe Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 32. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 33. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 34. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 35. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 36. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 37. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 38. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 39. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 40. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 41. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 42. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 43. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 44. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 45. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 46. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 47. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 48. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 49. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 50. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 51. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 52. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 53. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 54. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 55. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 56. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 57. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 58. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 59. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 60. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 61. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 62. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 63. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 64. Rest of Europe Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 65. Rest of Europe Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 66. Rest of Europe Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 67. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 68. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 69. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 70. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 71. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 72. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 73. Asia Pacific Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 74. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 75. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 76. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 77. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 78. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 79. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 80. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 81. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 82. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 83. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 84. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 85. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 86. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 87. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 88. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 89. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 90. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 91. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 92. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 93. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 94. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 95. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 96. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
Table 97. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 98. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 99. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 100. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 101. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 102. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 103. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 104. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 105. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 106. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 107. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 108. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 109. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 110. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 111. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 112. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 113. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 114. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 115. Middle East & Africa Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 116. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 117. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 118. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 119. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 120. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 121. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 122. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 123. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 124. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 125. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 126. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 127. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 128. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 129. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 130. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 131. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 132. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 133. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 134. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 135. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 136. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 137. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 138. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 139. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 140. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 141. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 142. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 143. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 144. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 145. South & Central America Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 146. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 147. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 148. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 149. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 150. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 151. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 152. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 153. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 154. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 155. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Low Grade
Table 156. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
Table 157. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 158. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 159. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 160. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 161. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 162. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 163. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 164. Organic Developments Done By Companies
Table 165. Inorganic Developments Done By Companies
Table 166. Glossary of Terms, glioma treatment market

List Of Figures

Figure 1. Glioma Treatment Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Glioma Treatment Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Glioma Treatment Market Revenue, Geography (US$ Mn), 2022 - 2030
Figure 7. Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 8. Astrocytoma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Oligodendroglioma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Oligodendroglioma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 12. Surgery: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Chemotherapy: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Radiation Therapy: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
Figure 17. Low Grade: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Grade I: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Grade II: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. High Grade: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Grade III: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Grade IV: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Hospital & Clinics: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Ambulatory Surgical Centers: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Glioma Treatment Market, 2022 ($Mn)
Figure 27. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. North America Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 29. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Europe Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 33. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Europe Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 35. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 42. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Asia Pacific Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 44. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 49. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 51. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. Middle East & Africa Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 53. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 56. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 58. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. South & Central America Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 60. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 62. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 63. Pre & Post Covid-19 Impact
Figure 64. Growth Strategies Done by the Companies in the Market, (%)

Product Code: TIPRE00029993

The global glioma treatment market is expected to reach US$ 8,292.5 million in 2030 from US$ 4,139.6 million in 2022. The market is projected to grow with a CAGR of 9.1% from 2022 to 2030.

The market's growth is the increasing prevalence of high-grade gliomas, including aggressive brain tumors such as glioblastomas, anaplastic astrocytomas, and oligodendrogliomas. However, high treatment costs hamper the market's growth to a certain extent.

Market Opportunities of Glioma Treatment Market

Brazil, India, China, Russia, and South Africa are among the fastest-growing economies in the world. The healthcare sectors in these countries and other developing economies are projected to expand rapidly in the coming years. The expected growth is due to changes in customer demand, increased awareness about healthcare services, and a continuous rise in the aging population. The global brain cancer treatment market is likely to grow significantly in the coming years with the proliferation of the healthcare sector.

Factors Hampering Glioma Treatment Market

Treating brain tumors can be expensive, and the high cost of treatments becomes a cause of stress and anxiety for patients. In addition to the treatment cost, people need to bear additional unplanned costs related to patient care. High medical costs compel people to discontinue their treatment plans, which may put their health at risk and lead to further costs in the future. According to the National Library of Medicine, the direct medical costs of newly diagnosed, Temozolomide-treated (TMZ) GBM are substantial in commercially insured patients, with estimated total cumulative costs of ~US$ 268,031. The healthcare costs incurred by patients with malignant brain tumors are 20 times higher than those borne by non-cancer control groups with the same demographics.

Glioma Treatment Market: Segmental Overview

The glioma treatment market is segmented based on type into astrocytoma, oligoastrocytoma, and oligodendroglioma. The astrocytoma segment held the largest market share in 2022. Furthermore, the segment is expected to register the highest CAGR from 2022 to 2030. An upsurge in activities to raise public awareness of this condition and its treatment, coupled with the increasing prevalence of this disease, are among the major factors fueling the glioma treatment market growth. In addition, companies in the market for the anaplastic astrocytoma segment may derive growth opportunities from growing R&D efforts and new, untapped market segments. Based on treatment, the glioma treatment market is segmented into surgery, chemotherapy, radiation therapy, and others. In 2022, the surgery segment held the market's largest share. Also, the same segment is expected to growing demand at the fastest CAGR from 2022 to 2030, owing to the surgery being the most preferred technique as it removes the tumor completely. Based on grade, the glioma treatment market is segmented into Low Grade and High Grade. In 2022, the high-grade segment held the market's largest share. Also, the same segment is expected to growing demand at the fastest CAGR from 2022 to 2030. Multiple research studies are underway to understand better high-grade tumors to develop more effective treatments or therapies. The glioma treatment market is segmented based on end-users into hospitals & clinics, and ambulatory care centres. In 2022, the hospital & clinics segment held the largest market share. Furthermore, the same segment is expected to anticipate growth in demand at the fastest CAGR from 2022 to 2030. Further, the increasing number of hospitals, adoption of advanced diagnostic platforms, and growing accessibility of hospitals in developing nations would offer lucrative opportunities for the growth of the glioma treatment market for the hospital segment during the forecast period.

Glioma Treatment Market: Geographical Overview

North America holds the largest share of the global glioma treatment market, whereas the Asia Pacific is the fastest-growing region in the global glioma treatment market. The market in North America is expected to grow during the forecast period, primarily driven by the increasing prevalence of brain tumors, technological advancements in glioma treatment, and the rising number of smokers. Asia Pacific registered the highest CAGR in the global glioma treatment testing market. The market in the region is expected to grow significantly in countries including China, India, and Japan in the coming years. The Asia Pacific market is expected to grow due to the increasing demand for brain cancer treatments and the rising prevalence of brain tumors. Therefore, the region holds huge potential for the glioma treatment market players to grow during the forecast period.

A few of the primary and secondary sources referred to while preparing the report on the glioma treatment market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and EPA (Environmental Protection Agency).

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the glioma treatment.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global glioma treatment, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global glioma treatment trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Glioma Treatment Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Global PEST Analysis

5. Glioma Treatment Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Initiatives by Regional and State Governments to Provide Patients Access to Treatment
- 5.1.2 Increase in Prevalence of High-Grade Glioma
5.2 Key Market Restraints
- 5.2.1 High Cost of Diagnosis
5.3 Key Market Opportunities
- 5.3.1 Advancements in Healthcare Sector in Emerging Economies
5.4 Future Trends
- 5.4.1 Surge in Drug Approvals for Glioma Treatment
5.5 Impact Analysis:

6. Glioma Treatment Market - Global Market Analysis

6.1 Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030

7. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease

7.1 Overview
7.2 Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
7.3 Astrocytoma
- 7.3.1 Overview
- 7.3.2 Astrocytoma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Oligoastrocytoma
- 7.4.1 Overview
- 7.4.2 Oligoastrocytoma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Oligodendroglioma
- 7.5.1 Overview
- 7.5.2 Oligodendroglioma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type

8.1 Overview
8.2 Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
8.3 Surgery
- 8.3.1 Overview
- 8.3.2 Surgery: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Chemotherapy
- 8.4.1 Overview
- 8.4.2 Chemotherapy: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Radiation Therapy
- 8.5.1 Overview
- 8.5.2 Radiation Therapy: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade

9.1 Overview
9.2 Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
9.3 Low Grade
- 9.3.1 Overview
- 9.3.2 Low Grade: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.3.2.1 Grade I: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.3.2.2 Grade II: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 High Grade
- 9.4.1 Overview
- 9.4.2 High Grade: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.4.2.1 Grade III: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.4.2.2 Grade IV: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospital & Clinics
- 10.3.1 Overview
- 10.3.2 Hospital & Clinics: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgical Centers: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

11. Glioma Treatment Market - Geographical Analysis

11.1 North America Glioma Treatment Market, Revenue and Forecast To 2030
- 11.1.1 Overview
- 11.1.2 North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.3 North America Glioma Treatment Market, by Disease
- 11.1.4 North America Glioma Treatment Market, by Treatment Type
- 11.1.5 North America Glioma Treatment Market, by Grade
  - 11.1.5.1 North America Glioma Treatment Market, by Low Grade
  - 11.1.5.2 North America Glioma Treatment Market, by High Grade
- 11.1.6 North America Glioma Treatment Market, by End User
- 11.1.7 North America Glioma Treatment Market, by Country
  - 11.1.7.1 US
    - 11.1.7.1.1 US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.7.1.2 US Glioma Treatment Market, by Disease
    - 11.1.7.1.3 US Glioma Treatment Market, by Treatment Type
    - 11.1.7.1.4 US Glioma Treatment Market, by Grade
    - 11.1.7.1.4.1 US Glioma Treatment Market, by Low Grade
    - 11.1.7.1.4.2 US Glioma Treatment Market, by High Grade
    - 11.1.7.1.5 US Glioma Treatment Market, by End User
  - 11.1.7.2 Canada
    - 11.1.7.2.1 Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.7.2.2 Canada Glioma Treatment Market, by Disease
    - 11.1.7.2.3 Canada Glioma Treatment Market, by Treatment Type
    - 11.1.7.2.4 Canada Glioma Treatment Market, by Grade
    - 11.1.7.2.4.1 Canada Glioma Treatment Market, by Low Grade
    - 11.1.7.2.4.2 Canada Glioma Treatment Market, by High Grade
    - 11.1.7.2.5 Canada Glioma Treatment Market, by End User
  - 11.1.7.3 Mexico
    - 11.1.7.3.1 Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.7.3.2 Mexico Glioma Treatment Market, by Disease
    - 11.1.7.3.3 Mexico Glioma Treatment Market, by Treatment Type
    - 11.1.7.3.4 Mexico Glioma Treatment Market, by Grade
    - 11.1.7.3.4.1 Mexico Glioma Treatment Market, by Low Grade
    - 11.1.7.3.4.2 Mexico Glioma Treatment Market, by High Grade
    - 11.1.7.3.5 Mexico Glioma Treatment Market, by End User
11.2 Europe Glioma Treatment Market, Revenue and Forecast to 2030
- 11.2.1 Overview
- 11.2.2 Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 11.2.3 Europe Glioma Treatment Market, by Disease
- 11.2.4 Europe Glioma Treatment Market, by Treatment Type
- 11.2.5 Europe Glioma Treatment Market, by Grade
  - 11.2.5.1 Europe Glioma Treatment Market, by Low Grade
  - 11.2.5.2 Europe Glioma Treatment Market, by High Grade
- 11.2.6 Europe Glioma Treatment Market, by End User
- 11.2.7 Europe Glioma Treatment Market, by Country
  - 11.2.7.1 UK
    - 11.2.7.1.1 UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.1.2 UK Glioma Treatment Market, by Disease
    - 11.2.7.1.3 UK Glioma Treatment Market, by Treatment Type
    - 11.2.7.1.4 UK Glioma Treatment Market, by Grade
    - 11.2.7.1.4.1 UK Glioma Treatment Market, by Low Grade
    - 11.2.7.1.4.2 UK Glioma Treatment Market, by High Grade
    - 11.2.7.1.5 UK Glioma Treatment Market, by End User
  - 11.2.7.2 Germany
    - 11.2.7.2.1 Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.2.2 Germany Glioma Treatment Market, by Disease
    - 11.2.7.2.3 Germany Glioma Treatment Market, by Treatment Type
    - 11.2.7.2.4 Germany Glioma Treatment Market, by Grade
    - 11.2.7.2.4.1 Germany Glioma Treatment Market, by Low Grade
    - 11.2.7.2.4.2 Germany Glioma Treatment Market, by High Grade
    - 11.2.7.2.5 Germany Glioma Treatment Market, by End User
  - 11.2.7.3 France
    - 11.2.7.3.1 France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.3.2 France Glioma Treatment Market, by Disease
    - 11.2.7.3.3 France Glioma Treatment Market, by Treatment Type
    - 11.2.7.3.4 France Glioma Treatment Market, by Grade
    - 11.2.7.3.4.1 France Glioma Treatment Market, by Low Grade
    - 11.2.7.3.4.2 France Glioma Treatment Market, by High Grade
    - 11.2.7.3.5 France Glioma Treatment Market, by End User
  - 11.2.7.4 Italy
    - 11.2.7.4.1 Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.4.2 Italy Glioma Treatment Market, by Disease
    - 11.2.7.4.3 Italy Glioma Treatment Market, by Treatment Type
    - 11.2.7.4.4 Italy Glioma Treatment Market, by Grade
    - 11.2.7.4.4.1 Italy Glioma Treatment Market, by Low Grade
    - 11.2.7.4.4.2 Italy Glioma Treatment Market, by High Grade
    - 11.2.7.4.5 Italy Glioma Treatment Market, by End User
  - 11.2.7.5 Spain
    - 11.2.7.5.1 Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.5.2 Spain Glioma Treatment Market, by Disease
    - 11.2.7.5.3 Spain Glioma Treatment Market, by Treatment Type
    - 11.2.7.5.4 Spain Glioma Treatment Market, by Grade
    - 11.2.7.5.4.1 Spain Glioma Treatment Market, by Low Grade
    - 11.2.7.5.4.2 Spain Glioma Treatment Market, by High Grade
    - 11.2.7.5.5 Spain Glioma Treatment Market, by End User
  - 11.2.7.6 Rest of Europe
    - 11.2.7.6.1 Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.2.7.6.2 Rest of Europe Glioma Treatment Market, by Disease
    - 11.2.7.6.3 Rest of Europe Glioma Treatment Market, by Treatment Type
    - 11.2.7.6.4 Rest of Europe Glioma Treatment Market, by Grade
    - 11.2.7.6.4.1 Rest of Europe Glioma Treatment Market, by Low Grade
    - 11.2.7.6.4.2 Rest of Europe Glioma Treatment Market, by High Grade
    - 11.2.7.6.5 Rest of Europe Glioma Treatment Market, by End User
11.3 Asia Pacific Glioma Treatment Market, Revenue and Forecast to 2030
- 11.3.1 Overview
- 11.3.2 Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 11.3.3 Asia Pacific Glioma Treatment Market, by Disease
- 11.3.4 Asia Pacific Glioma Treatment Market, by Treatment Type
- 11.3.5 Asia Pacific Glioma Treatment Market, by Grade
  - 11.3.5.1 Asia Pacific Glioma Treatment Market, by Low Grade
  - 11.3.5.2 Asia Pacific Glioma Treatment Market, by High Grade
- 11.3.6 Asia Pacific Glioma Treatment Market, by End User
- 11.3.7 Asia Pacific Glioma Treatment Market, by Country
  - 11.3.7.1 China
    - 11.3.7.1.1 China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.1.2 China Glioma Treatment Market, by Disease
    - 11.3.7.1.3 China Glioma Treatment Market, by Treatment Type
    - 11.3.7.1.4 China Glioma Treatment Market, by Grade
    - 11.3.7.1.4.1 China Glioma Treatment Market, by Low Grade
    - 11.3.7.1.4.2 China Glioma Treatment Market, by High Grade
    - 11.3.7.1.5 China Glioma Treatment Market, by End User
  - 11.3.7.2 Japan
    - 11.3.7.2.1 Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.2.2 Japan Glioma Treatment Market, by Disease
    - 11.3.7.2.3 Japan Glioma Treatment Market, by Treatment Type
    - 11.3.7.2.4 Japan Glioma Treatment Market, by Grade
    - 11.3.7.2.4.1 Japan Glioma Treatment Market, by Low Grade
    - 11.3.7.2.4.2 Japan Glioma Treatment Market, by High Grade
    - 11.3.7.2.5 Japan Glioma Treatment Market, by End User
  - 11.3.7.3 India
    - 11.3.7.3.1 India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.3.2 India Glioma Treatment Market, by Disease
    - 11.3.7.3.3 India Glioma Treatment Market, by Treatment Type
    - 11.3.7.3.4 India Glioma Treatment Market, by Grade
    - 11.3.7.3.4.1 India Glioma Treatment Market, by Low Grade
    - 11.3.7.3.4.2 India Glioma Treatment Market, by High Grade
    - 11.3.7.3.5 India Glioma Treatment Market, by End User
  - 11.3.7.4 South Korea
    - 11.3.7.4.1 South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.4.2 South Korea Glioma Treatment Market, by Disease
    - 11.3.7.4.3 South Korea Glioma Treatment Market, by Treatment Type
    - 11.3.7.4.4 South Korea Glioma Treatment Market, by Grade
    - 11.3.7.4.4.1 South Korea Glioma Treatment Market, by Low Grade
    - 11.3.7.4.4.2 South Korea Glioma Treatment Market, by High Grade
    - 11.3.7.4.5 South Korea Glioma Treatment Market, by End User
  - 11.3.7.5 Australia
    - 11.3.7.5.1 Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.5.2 Australia Glioma Treatment Market, by Disease
    - 11.3.7.5.3 Australia Glioma Treatment Market, by Treatment Type
    - 11.3.7.5.4 Australia Glioma Treatment Market, by Grade
    - 11.3.7.5.4.1 Australia Glioma Treatment Market, by Low Grade
    - 11.3.7.5.4.2 Australia Glioma Treatment Market, by High Grade
    - 11.3.7.5.5 Australia Glioma Treatment Market, by End User
  - 11.3.7.6 Rest of Asia Pacific
    - 11.3.7.6.1 Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.3.7.6.2 Rest of Asia Pacific Glioma Treatment Market, by Disease
    - 11.3.7.6.3 Rest of Asia Pacific Glioma Treatment Market, by Treatment Type
    - 11.3.7.6.4 Rest of Asia Pacific Glioma Treatment Market, by Grade
    - 11.3.7.6.4.1 Rest of Asia Pacific Glioma Treatment Market, by Low Grade
    - 11.3.7.6.4.2 Rest of Asia Pacific Glioma Treatment Market, by High Grade
    - 11.3.7.6.5 Rest of Asia Pacific Glioma Treatment Market, by End User
11.4 Middle East & Africa Glioma Treatment Market, Revenue and Forecast to 2030
- 11.4.1 Overview
- 11.4.2 Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 11.4.3 Middle East & Africa Glioma Treatment Market, by Disease
- 11.4.4 Middle East & Africa Glioma Treatment Market, by Treatment Type
- 11.4.5 Middle East & Africa Glioma Treatment Market, by Grade
  - 11.4.5.1 Middle East & Africa Glioma Treatment Market, by Low Grade
  - 11.4.5.2 Middle East & Africa Glioma Treatment Market, by High Grade
- 11.4.6 Middle East & Africa Glioma Treatment Market, by End User
- 11.4.7 Middle East & Africa Glioma Treatment Market, by Country
  - 11.4.7.1 Saudi Arabia
    - 11.4.7.1.1 Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.7.1.2 Saudi Arabia Glioma Treatment Market, by Disease
    - 11.4.7.1.3 Saudi Arabia Glioma Treatment Market, by Treatment Type
    - 11.4.7.1.4 Saudi Arabia Glioma Treatment Market, by Grade
    - 11.4.7.1.4.1 Saudi Arabia Glioma Treatment Market, by Low Grade
    - 11.4.7.1.4.2 Saudi Arabia Glioma Treatment Market, by High Grade
    - 11.4.7.1.5 Saudi Arabia Glioma Treatment Market, by End User
  - 11.4.7.2 South Africa
    - 11.4.7.2.1 South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.7.2.2 South Africa Glioma Treatment Market, by Disease
    - 11.4.7.2.3 South Africa Glioma Treatment Market, by Treatment Type
    - 11.4.7.2.4 South Africa Glioma Treatment Market, by Grade
    - 11.4.7.2.4.1 South Africa Glioma Treatment Market, by Low Grade
    - 11.4.7.2.4.2 South Africa Glioma Treatment Market, by High Grade
    - 11.4.7.2.5 South Africa Glioma Treatment Market, by End User
  - 11.4.7.3 UAE
    - 11.4.7.3.1 UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.7.3.2 UAE Glioma Treatment Market, by Disease
    - 11.4.7.3.3 UAE Glioma Treatment Market, by Treatment Type
    - 11.4.7.3.4 UAE Glioma Treatment Market, by Grade
    - 11.4.7.3.4.1 UAE Glioma Treatment Market, by Low Grade
    - 11.4.7.3.4.2 UAE Glioma Treatment Market, by High Grade
    - 11.4.7.3.5 UAE Glioma Treatment Market, by End User
  - 11.4.7.4 Rest of Middle East & Africa
    - 11.4.7.4.1 Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.4.7.4.2 Rest of Middle East & Africa Glioma Treatment Market, by Disease
    - 11.4.7.4.3 Rest of Middle East & Africa Glioma Treatment Market, by Treatment Type
    - 11.4.7.4.4 Rest of Middle East & Africa Glioma Treatment Market, by Grade
    - 11.4.7.4.4.1 Rest of Middle East & Africa Glioma Treatment Market, by Low Grade
    - 11.4.7.4.4.2 Rest of Middle East & Africa Glioma Treatment Market, by High Grade
    - 11.4.7.4.5 Rest of Middle East & Africa Glioma Treatment Market, by End User
11.5 South & Central America Glioma Treatment Market, Revenue and Forecast to 2030
- 11.5.1 Overview
- 11.5.2 South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 11.5.3 South & Central America Glioma Treatment Market, by Disease
- 11.5.4 South & Central America Glioma Treatment Market, by Treatment Type
- 11.5.5 South & Central America Glioma Treatment Market, by Grade
  - 11.5.5.1 South & Central America Glioma Treatment Market, by Low Grade
  - 11.5.5.2 South & Central America Glioma Treatment Market, by High Grade
- 11.5.6 South & Central America Glioma Treatment Market, by End User
  - 11.5.6.1 South & Central America Glioma Treatment Market, by Country
  - 11.5.6.2 Brazil
    - 11.5.6.2.1 Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.6.2.2 Brazil Glioma Treatment Market, by Disease
    - 11.5.6.2.3 Brazil Glioma Treatment Market, by Treatment Type
    - 11.5.6.2.4 Brazil Glioma Treatment Market, by Grade
    - 11.5.6.2.4.1 Brazil Glioma Treatment Market, by Low Grade
    - 11.5.6.2.4.2 Brazil Glioma Treatment Market, by High Grade
    - 11.5.6.2.5 Brazil Glioma Treatment Market, by End User
  - 11.5.6.3 Argentina
    - 11.5.6.3.1 Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.6.3.2 Argentina Glioma Treatment Market, by Disease
    - 11.5.6.3.3 Argentina Glioma Treatment Market, by Treatment Type
    - 11.5.6.3.4 Argentina Glioma Treatment Market, by Grade
    - 11.5.6.3.4.1 Argentina Glioma Treatment Market, by Low Grade
    - 11.5.6.3.4.2 Argentina Glioma Treatment Market, by High Grade
    - 11.5.6.3.5 Argentina Glioma Treatment Market, by End User
  - 11.5.6.4 Rest of South & Central America
    - 11.5.6.4.1 Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.5.6.4.2 Rest of South & Central America Glioma Treatment Market, by Disease
    - 11.5.6.4.3 Rest of South & Central America Glioma Treatment Market, by Treatment Type
    - 11.5.6.4.4 Rest of South & Central America Glioma Treatment Market, by Grade
    - 11.5.6.4.4.1 Rest of South & Central America Glioma Treatment Market, by Low Grade
    - 11.5.6.4.4.2 Rest of South & Central America Glioma Treatment Market, by High Grade
    - 11.5.6.4.5 Rest of South & Central America Glioma Treatment Market, by End User

12. Pre & Post Covid-19 Impact

12.1 Pre & Post Covid-19 Impact

13. Glioma Treatment Market Industry Landscape

13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
- 13.3.1 Overview
13.4 Inorganic Developments
- 13.4.1 Overview

14. Company Profiles

14.1 F. Hoffmann-La Roche Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Arbor Pharmaceuticals LLC
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Merck & Co Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Amgen Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Teva Pharmaceutical Industries Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Pfizer Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Amneal Pharmaceuticals Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Karyopharm Therapeutics Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Biocon Ltd
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About Us
15.2 Glossary of Terms

神経膠腫治療市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲：疾患別、治療タイプ別、グレード別、エンドユーザー別、地域別

Glioma Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease, Treatment Type, Grade, End User, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章神経膠腫治療市場の情勢

第5章神経膠腫治療市場-主要産業力学

第6章神経膠腫治療市場：世界市場分析

第7章神経膠腫治療市場神経膠腫治療の世界市場-2030年までの収益と予測：疾患別

第8章神経膠腫治療の世界市場：2030年までの収益と予測：治療タイプ別

第9章神経膠腫治療の世界市場：2030年までの収益と予測：グレード別

第10章神経膠腫治療の世界市場-エンドユーザー別収益と2030年までの予測

第11章神経膠腫治療市場- 地域別分析

第12章 COVID-19前後の影響

第13章神経膠腫治療神経膠腫治療市場の業界情勢

第14章企業プロファイル

第15章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Glioma Treatment Market Landscape

5. Glioma Treatment Market - Key Industry Dynamics

6. Glioma Treatment Market - Global Market Analysis

7. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease

8. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type

9. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade

10. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by End User

11. Glioma Treatment Market - Geographical Analysis

12. Pre & Post Covid-19 Impact

13. Glioma Treatment Market Industry Landscape

14. Company Profiles

15. Appendix

神経膠腫治療市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲：疾患別、治療タイプ別、グレード別、エンドユーザー別、地域別

Glioma Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease, Treatment Type, Grade, End User, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 神経膠腫治療市場の情勢

第5章 神経膠腫治療市場-主要産業力学

第6章 神経膠腫治療市場：世界市場分析

第7章 神経膠腫治療市場神経膠腫治療の世界市場-2030年までの収益と予測：疾患別

第8章 神経膠腫治療の世界市場：2030年までの収益と予測：治療タイプ別

第9章 神経膠腫治療の世界市場：2030年までの収益と予測：グレード別

第10章 神経膠腫治療の世界市場-エンドユーザー別収益と2030年までの予測

第11章 神経膠腫治療市場- 地域別分析

第12章 COVID-19前後の影響

第13章 神経膠腫治療神経膠腫治療市場の業界情勢

第14章 企業プロファイル

第15章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Glioma Treatment Market Landscape

5. Glioma Treatment Market - Key Industry Dynamics

6. Glioma Treatment Market - Global Market Analysis

7. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease

8. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type

9. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade

10. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by End User

11. Glioma Treatment Market - Geographical Analysis

12. Pre & Post Covid-19 Impact

13. Glioma Treatment Market Industry Landscape

14. Company Profiles

15. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章神経膠腫治療市場の情勢

第5章神経膠腫治療市場-主要産業力学

第6章神経膠腫治療市場：世界市場分析

第7章神経膠腫治療市場神経膠腫治療の世界市場-2030年までの収益と予測：疾患別

第8章神経膠腫治療の世界市場：2030年までの収益と予測：治療タイプ別

第9章神経膠腫治療の世界市場：2030年までの収益と予測：グレード別

第10章神経膠腫治療の世界市場-エンドユーザー別収益と2030年までの予測

第11章神経膠腫治療市場- 地域別分析

第13章神経膠腫治療神経膠腫治療市場の業界情勢

第14章企業プロファイル

第15章付録